Publications in collaboration with researchers from Pierre and Marie Curie University (51)

2024

  1. A Mouse Model of Hepatocellular Carcinoma Induced by Streptozotocin and High-Fat Diet

    Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 67-75

  2. A Mouse Model of Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma Induced by Western Diet and Carbon Tetrachloride

    Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 57-65

  3. Acyl-CoA binding protein for the experimental treatment of anorexia

    Science translational medicine, Vol. 16, Núm. 760, pp. eadl0715

  4. Biomarker Identification in Liver Cancers Using Desorption Electrospray Ionization Mass Spectrometry (DESI-MS) Imaging: An Approach for Spatially Resolved Metabolomics

    Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 199-209

  5. Inhibition of acyl-CoA binding protein (ACBP) by means of a GABAARγ2-derived peptide

    Cell Death and Disease, Vol. 15, Núm. 4

  6. Isolation of Primary Mouse Hepatocytes and Non-Parenchymal Cells from a Liver with Precancerous Lesions

    Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 109-128

  7. Mineralocorticoid receptor (MR) antagonist eplerenone and MR modulator balcinrenone prevent renal extracellular matrix remodeling and inflammation via the MR/proteoglycan/TLR4 pathway

    Clinical science (London, England : 1979), Vol. 138, Núm. 16, pp. 1025-1038

  8. Orthotopic Model of Hepatocellular Carcinoma in Mice

    Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 1-13

  9. Targeted Analysis of Glycerophospholipids and Mono-, Di-, or Tri-Acylglycerides in Liver Cancer

    Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 189-198

2023

  1. Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

2022

  1. An obesogenic feedforward loop involving PPARγ, acyl-CoA binding protein and GABAA receptor

    Cell Death and Disease, Vol. 13, Núm. 4

  2. Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury

    International Journal of Molecular Sciences, Vol. 23, Núm. 12

  3. Correction: An obesogenic feedforward loop involving PPARγ, acyl-CoA binding protein and GABA receptor (Cell Death & Disease, (2022), 13, 4, (356), 10.1038/s41419-022-04834-5)

    Cell Death and Disease

  4. Mineralocorticoid Receptor Antagonism Prevents the Synergistic Effect of Metabolic Challenge and Chronic Kidney Disease on Renal Fibrosis and Inflammation in Mice

    Frontiers in Physiology, Vol. 13

  5. The myeloid mineralocorticoid receptor regulates dermal angiogenesis and inflammation in glucocorticoid-induced impaired wound healing

    British Journal of Pharmacology, Vol. 179, Núm. 23, pp. 5222-5232

2021

  1. Clonogenic Assays to Detect Cell Fate in Mitotic Catastrophe

    Methods in Molecular Biology (Humana Press Inc.), pp. 227-239

  2. Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index

    Cell Death and Disease, Vol. 12, Núm. 6

  3. In Vivo Imaging of Orthotopic Lung Cancer Models in Mice

    Methods in Molecular Biology (Humana Press Inc.), pp. 199-212

  4. Paradoxical implication of BAX/BAK in the persistence of tetraploid cells

    Cell Death and Disease, Vol. 12, Núm. 11

2020

  1. Antibody-mediated neutralization of ACBP/DBI has anorexigenic and lipolytic effects

    Adipocyte, Vol. 9, Núm. 1, pp. 116-119